Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Ciprofloxacin Otic bulk supplier for pharma manufacturers

Ciprofloxacin Otic 0.2% Suppliers & Bulk Manufacturers

Available Forms: Ear drops

Available Strengths: 0.2%

Reference Brands: US: Ciprofloxacin Otic (Ciloxan)

Category: ENT

Ciprofloxacin ear drops are a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, preventing bacterial replication. They effectively treat bacterial otitis media and external ear infections. Benefits include rapid infection control, decreased symptoms, prevention of complications, and improved ear health worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Ciprofloxacin ear drops, marketed as Ciloxan, are approved in the US by the FDA and in the EU via EMA for treating bacterial ear infections. Regulatory approval requires detailed dossiers including clinical efficacy, safety data, manufacturing practices, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Proper regional adherence supports swift approval, safe use, and global availability, enabling effective treatment for bacterial ear infections worldwide through high-quality, regionally approved ciprofloxacin ear drops.

Ciprofloxacin Otic — third party manufacturing & bulk supply

Ciprofloxacin Otic 0.2% is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Ciprofloxacin Otic is supplied as Ear drops — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ciprofloxacin Otic listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Ciprofloxacin Otic →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Ciprofloxacin otic is used to treat bacterial infections of the external ear canal, including otitis externa (swimmer’s ear) and other bacterial ear infections. It helps reduce pain, swelling, redness, and discharge by eliminating the bacteria causing the infection.

Ciprofloxacin otic contains the active ingredient ciprofloxacin hydrochloride, a fluoroquinolone antibiotic. It works by inhibiting bacterial DNA gyrase and topoisomerase IV enzymes, preventing bacterial replication and leading to bacterial cell death.

Ciprofloxacin otic is marketed under trade names such as Cipro Otic, Ciproxin Otic, and Ciloxan Otic Solution.

Ciprofloxacin otic products are manufactured by multiple pharmaceutical companies, including Bayer (Ciloxan) and other regional manufacturers producing branded and generic versions globally.

The generic name is ciprofloxacin hydrochloride.

Brand names include Cipro Otic, Ciproxin Otic, Ciloxan Otic Solution, and other branded generic products.

Ciprofloxacin otic is manufactured by pharmaceutical companies in the United States, Europe, India, and other global pharmaceutical markets.

Related Products

Hexetidine

Strength:
0.1% (w/v), 0.1% (w/v)

Form: Mouthwash

Reference Brands: Oraldene (UK), Hexoral (EU)

View Details
Cefuroxime Axetil Tablets

Strength:
250 mg, 500 mg

Form: Tablets

Reference Brands: Ceftin(US)

View Details
Azithromycin Suspension

Strength:
100 mg/5 mL

Form: Suspension

Reference Brands: Zithromax, Z-Pak(US), Azithral(India)

View Details
Hexidine Gargle

Strength:
0.12% or 0.2% chlorhexidine gluconate

Form: Liquid Gargle

Reference Brands: Hexidine(US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.